Kenyan investors remain locked out of the lucrative medicine manufacturing business, denying them billions of shillings, a new report has shown.
The Pharmaceutical Industry Diagnostic Report 2020 notes that Kenyan manufacturers hold only 30 percent of the Sh109.6 billion ($1 billion) local pharmaceutical market.
